Latest news
April 1, 2019
Debiopharm releases results of 3 key oncology compound programs at the 2019 American Association for Cancer Research (AACR) Conference in…
March 12, 2019
ACTEON has entered into exclusive negotiations to acquire the Dental Division of VILLA SISTEMI MEDICALI
February 26, 2019
Debiopharm International SA Initiates a Clinical Trial Phase II study evaluating afabicin in Bone and Joint Infections
February 14, 2019
Debiopharm International SA Initiates FUZE, a Clinical Trial Phase II study evaluating Debio 1347 in Advanced Solid Tumors harboring an…
January 29, 2019
Challenge pour la Qualité de vie du patient 2019 : l’appel à projets est ouvert !
January 7, 2019
Debiopharm Group regains the commercial rights to Trelstar® (Triptorelin pamoate) and looks for new partners in North America